# Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells

> **NCT00630721** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 56 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** IFNbeta-1b

## Key facts

- **NCT ID:** NCT00630721
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-05-15
- **Final completion:** 2011-03-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630721, "Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00630721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*